Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00313352
Other study ID # 0293-2006
Secondary ID
Status Completed
Phase N/A
First received April 10, 2006
Last updated November 8, 2013
Start date January 1997
Est. completion date March 2007

Study information

Verified date November 2013
Source Emory University
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

The purpose of this chart review study is to examine the effects of beta -adrenergic blocking agents on systemic ventricular dimensions, systemic atrioventricular valve function and exercise tolerance in patients with transposition of the great arteries (TGA) and systemic ventricular dysfunction.


Description:

Many children with transposition of the great arteries who underwent atrial inflow correction using the Mustard or Senning operation are now adults. While their short- and midterm prognosis have been good, their life expectancy is limited by the onset of serious cardiovascular complications including arrhythmias, systemic (morphologically right) ventricular dysfunction and sudden cardiac death.

The ability of the morphological right ventricle (RV) to support the systemic circulation is limited. It has been postulated that perfusion and wall motion abnormalities are common in the systemic RV late (10-20 years) after Mustard's operation. Poor ventricular function causes progressive RV enlargement and systemic atrioventricular valve insufficiency, resulting in congestive heart failure (CHF). Deterioration in systolic function of the systemic ventricle is a major determinant of survival in these patients.

Little is known about the most effective therapy of progressive systemic RV dysfunction in these patients. Despite several recent studies demonstrating the benefit of beta-adrenergic blocking agents in improved left ventricular function in adults with heart failure and left ventricular dysfunction, there have been no reports of the use of beta-adrenergic blocking agents in adult patients with ventricular dysfunction due to congenital heart disease. This data collection study will be a single center, retrospective study; a chart review of patients with TGA (either DTGA or LTGA) and systemic right ventricular dysfunction.

Patient Population:

Patients followed-up at Emory University Hospital and The Emory Clinic who meet the following inclusion criteria:

1. Age ≥ 18 years

2. Diagnosis: Complete d-TGA or Congenitally Corrected TGA with a systemic morphologic right ventricle

3. Patients > 18 years of age seen at The Emory Clinic and Emory University Hospital with transposition of the great arteries

4. Systemic ventricular ejection fraction < 50% with or without a clinical diagnosis of heart failure

5. Echocardiogram performed between January 1, 1997and February 1, 2006

Future Directions:

The effects of beta-adrenergic blocking agents in patients with TGA and congestive heart failure due to systemic ventricular dysfunction have never been studied. To our knowledge, only one case report suggests that carvedilol may potentially improve systemic ventricular functions and volumes in these patients. This study will identify the potential merits of beta-blocker therapy in patients with TGA and CHF and could theoretically lead to a multi-institutional prospective analysis of beta-blocker therapy in adult patients with congenial heart disease and CHF.


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date March 2007
Est. primary completion date March 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients followed-up at Emory University Hospital and The Emory Clinic who meet the following inclusion criteria:

1. Age = 18 years

2. Diagnosis: Complete d-TGA or Congenitally Corrected TGA with a systemic morphologic right ventricle

3. Patients > 18 years of age seen at The Emory Clinic and Emory University Hospital with transposition of the great arteries

4. Systemic ventricular ejection fraction < 50% with or without a clinical diagnosis of heart failure

5. Echocardiogram performed between January 1, 1997and February 1, 2006

Exclusion Criteria:

- Those who do not meet inclusion criteria.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Emory University Atlanta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Emory University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary functional class beta blockers improved functional class in patient's with transposition and systemic right ventricles 6 months to 5 years No
See also
  Status Clinical Trial Phase
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Not yet recruiting NCT03291678 - Impact of Percutaneous Laparoscopic Assisted Internal Ring Ligation During Lap Orchiopexy N/A
Completed NCT00489788 - Predictors for Pulmonary Valve Replacement - Anatomic and Hemodynamic Using MRI N/A
Terminated NCT00268060 - Infant Medical Records: Case Report Proposal N/A
Not yet recruiting NCT05955794 - Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes N/A
Completed NCT00257517 - Multisite Feeding Study: Home Surveillance and Feeding Strategies in Infants With Complex Single Ventricle N/A
Completed NCT00478296 - Pulmonary Hypertension in Trisomy 21 Patients N/A
Completed NCT04556487 - Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Terminated NCT00261989 - Pulse Oximetry Readings and Hourly Variation in Oximetry Readings With CHD N/A
Completed NCT00211081 - Spironolactone in Patients With Single Ventricle Heart N/A
Terminated NCT00268099 - Optimal Timing for Repair of Right-to-Left Shunt Lesions N/A
Active, not recruiting NCT05752019 - TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
Completed NCT00490295 - Biomarkers for Detection of Brain Ischemia N/A
Terminated NCT00327899 - Home Inotropic Therapy in Children N/A
Terminated NCT00229905 - Child With Anomalous Drainage of IVC to Left Atrium N/A
Completed NCT00277901 - MRI Assessment of RV Function: Patients With TOF or Aortic Coarctation N/A
Terminated NCT00366314 - Frequency of Accessing Central Lines for Blood Samples N/A
Terminated NCT00268034 - Left Ventricular Aneurysms in Children N/A
Completed NCT00366847 - Computer Modeling of Congenital Heart Disease N/A
Withdrawn NCT00460824 - A Retrospective Review - Anti-HLA Antibodies N/A